Steve Cohen’s Investment in Cybin: A Game-Changer in Psychedelic Medicine
Strategic investments often serve as crucial milestones. Recently, hedge fund billionaire Steve Cohen made headlines by purchasing over 18 million shares of Cybin, a pioneering company in the psychedelic medicine…